On the heels of a private equity buyout campaign that ultimately fell flat, Bavarian Nordic’s board chair is stepping aside.

Both Eli Lilly and Novo Nordisk are denying a telehealth company’s claim of having struck partnerships with the two companies ...

Kyowa Kirin’s big bet on Kura Oncology has paid off in short order, delivering an FDA approval for a medicine to treat a ...

The project will expand Boryung’s oral penicillin antibiotic production line at its campus in Ansan, South Korea, from 2,777 ...

Gilead Sciences has developed an industry-leading HIV portfolio in recent years with its megablockbuster daily treatment ...